EFG Asset Management North America Corp. Sells 3,895 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• EFG Asset Management North America Corp. reduced its stake in Intuitive Surgical by 20.9%, holding 14,759 shares worth approximately $7.3 million as of the latest reporting period.
• Insider trading activity showed significant stock sales, with EVP Myriam Curet selling 4,500 shares and CEO Gary S. Guthart selling 29,360 shares, representing a 92.73% and 59.69% decrease in their positions respectively.
• Intuitive Surgical's stock has a current market capitalization of $158.15 billion and analysts forecast a strong growth outlook with a consensus price target of around $595.95.

EFG Asset Management North America Corp. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 20.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,759 shares of the medical equipment provider's stock after selling 3,895 shares during the quarter. Intuitive Surgical makes up approximately 1.2% of EFG Asset Management North America Corp.'s portfolio, making the stock its 10th largest position. EFG Asset Management North America Corp.'s holdings in Intuitive Surgical were worth $7,309,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in ISRG. Nuveen LLC acquired a new position in shares of Intuitive Surgical in the first quarter worth about $1,715,899,000. GAMMA Investing LLC boosted its holdings in shares of Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after buying an additional 3,022,979 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Intuitive Surgical by 26.1% in the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after buying an additional 584,375 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock worth $1,732,975,000 after buying an additional 457,080 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock worth $16,178,258,000 after buying an additional 453,335 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last 90 days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

ISRG traded up $3.14 during midday trading on Monday, hitting $470.00. 1,936,330 shares of the company's stock traded hands, compared to its average volume of 2,023,255. The company has a market cap of $168.49 billion, a PE ratio of 65.55, a price-to-earnings-growth ratio of 4.89 and a beta of 1.61. The stock's fifty day simple moving average is $494.00 and its 200-day simple moving average is $512.08. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the firm earned $1.78 earnings per share. The company's revenue for the quarter was up 21.4% on a year-over-year basis. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. BTIG Research increased their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Citigroup reissued a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial increased their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Finally, Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.